FCSR Logo

  •  
  • Chi Siamo
    • Personalità giuridica
    • Legge 4 agosto 2017 n. 124
  • Ricerca
  • WHO Collaborating Centre
  • Enti Finanziatori
  • Contatti
  • Sostienici

Enhancement of NKG2DL-induced anti-tumor response in Hodgkin lymphoma: ERp5 and ADAMs as Therapeutic targets

Published gennaio 24, 2013 at 295 × 198 in Enhancement of NKG2DL-induced anti-tumor response in Hodgkin lymphoma: ERp5 and ADAMs as Therapeutic targets.
← Previous Next →
Statuto | Codice Etico | Modello di Organizzazione, Gestione e Controllo | Area Stampa | Policy of Research Misconduct | Benefici fiscali | Financial Conflict Of Interest Policy | FCSR Cookie Policy | Privacy Policy

Copyright Reserved ©. 2025